2004, Number 6
<< Back Next >>
Med Cutan Iber Lat Am 2004; 32 (6)
Unilateral multiple facial angiofibromas
Alonso PML, Zambrano CB, Eusebio ME, Jaén OP, Cuevas SJ
Language: Spanish
References: 30
Page: 249-253
PDF size: 348.17 Kb.
ABSTRACT
Multiple bilateral facial angiofibromas are pathognomonic for the diagnosis of tuberous sclerosis. Their unilateral presence and without other criteria of tuberous sclerosis has been exceptionally referred (8 cases). We present two women with unilateral multiple facial angiofibromas. In the first patient’s daughter three facial angiofibromas were detected without segmental distribution. The second case presented acquired blindness homolateral to the cutaneous lesions. We think that a genomic mosaicism for tuberous sclerosis by a postzygotic localized mutation could explain this segmental phenotypic expression. We discuss the eventual hereditary transmission of the process in the first case and the possible deep systemic localized affectation in the second.
REFERENCES
Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol 1996; 135: 1-5.
Roach ES, Gomez MR, Northup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13: 624-8.
Darling TN, Skarulis M, Steinberg SM, Marx SJ, et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 1997; 133: 853-7.
Phillips ChM, Rye B. Neurofibromatosis type 1 and tuberous sclerosis: A case of a double phakomatosis. J Am Acad Dermatol 1994; 31: 799-800.
McGrae JD, Hashimoto K. Unilateral facial angiofibromas- a segmental form of tuberous sclerosis. Br J Dermatol 1996; 134: 727-30.
Anliker MD, Dummer R, Burg G. Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis? Dermatology 1997; 195: 176-8.
García Muret MP, Pujol RM, de Moragas JM. Angiofibromes multiples et unilatéraux de la face: forme fruste de la sclérose tubéreuse de Bourneville. Ann Dermatol Venereol 1998; 125: 325-7.
Silvestre JF, Bañuls J, Ramón R, Guijarro J, et al. Unilateral multiple tuberous sclerosis: A mosaic form of tuberous sclerosis. J Am Acad Dermatol 2000; 43: 127-9.
Del Pozo J, Martínez W, Calvo R, Almagro M, et al. Unilateral angiofibromas. An oligosymptomatic and segmentary form of tuberous sclerosis. Eur J Dermatol 2002; 12: 262.
Trauner M, Ruben B, Lynch P. Segmental tuberous sclerosis presenting as unilateral facial angiofibromas. J Am Acad Dermatol 2003; 49: S164-6.
García Muret MP, Pujol RM. Angiofibromes multiples et unilatéraux de la face. Ann Dermatol Venereol 2000; 127: 210-3.
Nagore E, Sánchez JM, Fortea JM, Aliaga A. Fibroma periungueal solitario: ¿se puede descartar la existencia de una esclerosis tuberosa? Actas Dermosifiliogr 1998; 89: 203-5.
Schnur RE. Tuberous sclerosis. The persistent challenge of clinical diagnosis. Arch Dermatol 1995; 131: 1460-2.
Zeller J, Friedmann D, Clerici T, Revuz J. The significance of a single periungueal fibroma: report of seven cases. Arch Dermatol 1995; 131: 1465-6.
Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001; 56: 1433-43.
Yates JR, Bakel I, Sepp T, Payne SJ, et al: Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum Mol Genet 1997; 13: 2265-9.
Rose VM, Au KS, Pollom G, Roach ES, et al. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 1999; 64: 986-92.18. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Human Genet 2000; 107: 97-114.
MacCollin M, Kwiatkowski DJ. Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1. Curr Opin Neurol 2001; 14: 163-9.
Verhoef S, Radek V, Essen T, Bakker L, et al. Somatic mosaicism and clinical variation in tuberous sclerosis complex. Lancet 1995; 345: 202.
Kwiatkowski J, Wigowska J, Napierala D, Slomski R, et al. Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999; 340: 703-7.
Fryer AE, Connor JM, Povey S, Yates JR, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987; 1: 659-61.
European Crhomosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305-15.
Happle R. Mosaicism in human skin. Undertanding the patterns and mechanisms. Arch Dermatol 1993; 129: 1460-70.
Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997; 133: 1505-9.
Happle R. Pourquoi les génodermatoses autosomiques dominantes ont-elles deux expressions segmentaires différentes? Ann Dermatol Venereol 2001; 128: 109-10.
Sanchez N, Wick M, Perry H. Adenoma sebaceum of Pringle: A clinicopathologic review, with a discussion of related pathologic entities. J Cutan Pathol 1981; 8: 395-403.
Robertson DM. Ophthalmic manifestations of tuberous sclerosis. Ann N Y Acas Sci 1991; 615: 17-25.
Del Pozo J, Almagro M, Martínez W, Peña C, et al. Neurofibromatosis segmentaria. Presentación de 8 casos. Piel 2000; 15: 4-10.
Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101: 178-80.
Roach ES, DiMario FJ, Kandt RS, et al. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999; 14: 401-7.